[PDF][PDF] Pharmacokinetics of factor VIII in hemophilia A patients assessed by frequency response method

M Durisová, L Dedík, A Bátorová… - Methods and findings …, 1998 - researchgate.net
… model or noncompartment approach is used (7, 8). … frequency response method in modeling
pharmacokinetic systems describing the fate of F VIII administered to hemophilia A patients

Hemophilia prophylaxis adherence and bleeding using a tailored, frequency‐escalated approach: The Canadian Hemophilia Primary Prophylaxis Study

S Dover, VS Blanchette, D Wrathall… - … and Practice in …, 2020 - Wiley Online Library
… of 56 boys with severe hemophilia A to tailored, frequency-escalated prophylaxis with an …
than the general hemophilia population. For the CHPS, we excluded patients and families …

Annual bleeding rates: pitfalls of clinical trial outcomes in hemophilia patients

C Keipert, M Müller‐Olling, F Gauly… - Clinical and …, 2020 - Wiley Online Library
… basic characteristics of the ABR endpoint. In addition, we analyzed study protocols from
contemporary hemophilia … to characterize differences in the methodology of ABR estimation. The …

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B

JM Soucie, PE Monahan, R Kulkarni… - Blood …, 2018 - ashpublications.org
… with hemophilia A to have undergone an orthopedic procedure… higher among hemophilia
A than hemophilia B patients, and … to prevent all joint bleeding in US males with hemophilia. …

Patient and parent preferences for characteristics of prophylactic treatment in hemophilia

R Furlan, S Krishnan, J Vietri - Patient preference and adherence, 2015 - Taylor & Francis
… Three of the six attributes accounted for >88% of the total impact of the elements included
in the study on the treatment decision process in hemophilia A ( Figure 2 ). Frequency of …

[HTML][HTML] The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay

T Matsumoto, M Shima, M Takeyama, K Yoshida… - Journal of thrombosis …, 2006 - Elsevier
… It is suggested that the application of this methodology should increase our understanding
of the clinical significance of factors levels that could not be measured previously and thus …

[HTML][HTML] Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations

A Iorio, AN Edginton, V Blanchette, J Blatny… - Research and practice …, 2018 - Elsevier
… In addition, utilization of a PopPK method to derive individual PK … with hemophilia. To
facilitate understanding this potential we will compare and contrast it to the traditional approach. …

[HTML][HTML] A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management

LA Valentino, V Mamonov, A Hellmann… - Journal of thrombosis …, 2012 - Elsevier
… Background: Prophylaxis with factor (F)VIII is considered the optimal treatment for
managing hemophilia A patients without inhibitors. Objectives: To compare the efficacy of two …

Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method

E Berntorp, G Spotts, L Patrone… - Biologics: Targets and …, 2014 - Taylor & Francis
patients with moderately severe to severe hemophilia A and summarize advances in tailoring
therapy to patient-… -PFM leading toward personalized care for patients with hemophilia A. …

Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A

P Chowdary, E Fosbury, A Riddell… - Journal of blood …, 2016 - Taylor & Francis
… The use of EHL FVIII products in boys with severe hemophilia A will be an evolving process
… A pragmatic approach will be necessary to manage both clinician and patient expectations, …